胶质母细胞瘤切除术中脑室进入与生存期缩短及远处复发风险增加相关
该回顾性分析纳入2013至2023年在匹兹堡大学医学中心治疗的新诊断幕上胶质母细胞瘤患者282例,脑室进入发生率为38.3%(n=108)。脑室进入组中位总生存期显著低于非脑室进入组(12个月 vs 18个月,P<.001),且脑室进入是生存期缩短的独立危险因素(HR 1.62 [1.12-2.34],P=.001)。脑室进入组远处实质复发和软脑膜播散率均显著更高,脑室进入是多变量逻辑回归中远处复发/软脑膜播散的独立预测因素(OR 4.7 [2.11-10.4],P<.001)。
要点
- 脑室进入组中位总生存期12个月 vs 非脑室进入组18个月,P<.001。
- 脑室进入组远处实质复发63.9% vs 非脑室进入组39.7%,P<.001;软脑膜播散23.1% vs 13.2%,P=.035。
核心结论
- 数据提示胶质母细胞瘤切除术中脑室进入是生存期缩短及远处复发/软脑膜播散增加的显著独立危险因素。
- 作者认为在最大化肿瘤切除的同时,神经外科医生必须考虑脑室进入可能带来的不良结局,因其可能削弱大体全切除的生存获益。
- 作者建议需要前瞻性研究以更好地理解胶质母细胞瘤手术中脑室进入的风险与获益。
研究设计与样本
- 回顾性分析2013至2023年在匹兹堡大学医学中心治疗的新诊断幕上胶质母细胞瘤患者。
- 通过术前和术后影像识别室管膜下区受累、肿瘤大小和切除范围。
- 通过手术记录和术后影像回顾识别脑室进入。
- 共282例患者符合纳入标准。
主要发现
- 脑室进入发生于38.3%(n=108)的患者,在室管膜下区接触肿瘤的患者中更常见(P<.001)。
- 脑室进入组中位总生存期显著低于非脑室进入组(12个月 vs 18个月,P<.001)。
- 调整已知预后因素和室管膜下区接触后,脑室进入是总生存期缩短的独立危险因素(HR 1.62 [1.12-2.34],P=.001)。
- 仅脑室进入组患者发生术后脑积水(n=4,1.4%,P=.021)并放置脑室外引流(n=6,2.1%,P=.003)。
- 脑室进入组远处实质复发和软脑膜播散率显著高于非脑室进入组(63.9% vs 39.7%,P<.001;23.1% vs 13.2%,P=.035),脑室进入是多变量逻辑回归中远处复发/软脑膜播散的独立预测因素(OR 4.7 [2.11-10.4],P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Although subventricular zone (SVZ) involvement is known to correlate with more aggressive tumor behavior and reduced survival in glioblastoma (GBM), the role of ventricular entry (VE) on outcomes is less clear and remains debated. This study aims to investigate the impact of VE on outcomes and overall survival (OS) in GBM. METHODS: A retrospective analysis of patients with newly diagnosed supratentorial GBMtreated between 2013 and 2023 at the University of Pittsburgh Medical Center was performed. SVZ involvement, size, and extent of resection were identified through preoperative and postoperative imaging. VE was identified through operative notes and postoperative imaging review. RESULTS: A total of 282 patients met inclusion criteria. VE occurred in 38.3% (n = 108) of patients and was more common in those with SVZ-contacting tumors ( P < .001). Patients who had VE had significantly lower median OS compared with non-VE (12 months vs 18 months, P < .001). VE was identified as an independent risk factor for decreased OS in patients with GBM, after adjusting for well-known prognostic factors and SVZ contact (hazard ratios: 1.62 [1.12-2.34], P = .001). Only patients who had VE developed postoperative hydrocephalus (n = 4, 1.4%, P = .021) and had external ventricular drain placed (n = 6, 2.1%, P = .003). Distant parenchymal recurrence and leptomeningeal dissemination (LMD) rates were significantly higher in the VE group compared with the non-VE group (63.9% vs 39.7%, P < .001, and 23.1% vs 13.2%, P = .035), and VE emerged as an independent predictor of distant recurrences/LMDs in multivariable logistic regression (odds ratio: 4.7 [2.11-10.4], P < .001). CONCLUSION: Our data suggest that VE during GBM resection is a significant independent risk factor for decreased survival and increased distant recurrence/LMD. While maximizing tumor resection remains critical, neurosurgeons must consider the potential adverse outcomes associated with VE because it may diminish the survival benefits of gross-total resection. Prospective studies are warranted to better understand the risks and benefits of VE in GBM surgery.
引用
- Gecici NN, Habib A, Mallela AN, et al. Ventricular Entry During Glioblastoma Resection is Associated With Reduced Survival and Increased Risk of Distant Recurrence. Neurosurgery. 2025. PMID: 40178259. doi:10.1227/neu.0000000000003431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。